HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oncogenic kinase NPM/ALK induces expression of HIF1α mRNA.

Abstract
The mechanisms of malignant cell transformation mediated by the oncogenic anaplastic lymphoma kinase (ALK) tyrosine kinase remain only partially understood. In this study, we report that T-cell lymphoma (TCL) cells carrying the nucleophosmin (NPM)/ALK fusion protein (ALK+ TCL) strongly express hypoxia-induced factor 1α (HIF1α) mRNA, even under normoxic conditions, and markedly upregulate HIF1α protein expression under hypoxia. HIF1α expression is strictly dependent on the expression and enzymatic activity of NPM/ALK, as shown in BaF3 cells transfected with wild-type NPM/ALK and kinase-inactive NPM/ALK K210R mutant and by the inhibition of the NPM/ALK function in ALK+ TCL cells by a small-molecule ALK inhibitor. NPM/ALK induces HIF1α expression by upregulating its gene transcription through its key signal transmitter signal transducer and activator of transcription 3 (STAT3), which binds to the HIF1α gene promoter as shown by the chromatin immunoprecipitation assay and is required for HIF1α gene expression as demonstrated by its small interfering RNA-mediated depletion. In turn, depletion of HIF1α increases mammalian target of rapamycin complex 1 activation, cell growth and proliferation and decreases vascular endothelial growth factor synthesis. These results identify a novel cell-transforming property of NPM/ALK, namely its ability to induce the expression of HIF1α, a protein with an important role in carcinogenesis. These results also provide another rationale to therapeutically target NPM/ALK and STAT3 in ALK+ TCL.
AuthorsM Marzec, X Liu, W Wong, Y Yang, T Pasha, K Kantekure, P Zhang, A Woetmann, M Cheng, N Odum, M A Wasik
JournalOncogene (Oncogene) Vol. 30 Issue 11 Pg. 1372-8 (Mar 17 2011) ISSN: 1476-5594 [Electronic] England
PMID21102525 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • NPM1 protein, human
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • RNA, Small Interfering
  • Nucleophosmin
  • Phosphotransferases
  • Protein-Tyrosine Kinases
Topics
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hypoxia
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics)
  • Lymphoma, T-Cell (genetics, metabolism, pathology)
  • Nuclear Proteins (metabolism)
  • Nucleophosmin
  • Oncogene Proteins, Fusion (antagonists & inhibitors, genetics, metabolism)
  • Phosphotransferases (metabolism)
  • Protein-Tyrosine Kinases (antagonists & inhibitors, genetics, metabolism)
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (genetics, metabolism)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: